Helen Albert

Phenomix Sciences, a biotech focusing on obesity phenotyping and biomarker testing, will partner with genetic testing and counseling provider InformedDNA to provide targeted obesity treatment based on underlying biology.

Research led by the Amsterdam University Medical Center (UMC) shows a specific risk score can predict the risk of patients' developing epilepsy after experiencing a cerebral venous thrombosis, a type of rare stroke.

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major depressive disorder and generalized anxiety disorder.

Researchers have developed a new CAR-T cell cancer therapy that can be switched on and off using oral medicines that are already approved.

An artificial intelligence (AI)-based tool developed at the University of Coventry in the U.K. can help enhance decision making about kidney transplants by providing information about likely outcomes.

Alto Neuroscience has a focus on developing new neuropsychiatric medications. The company is using a combination of artificial intelligence (AI), brain

A Phase I/II study of Lexeo Therapeutics' gene therapy to treat patients with Alzheimer's associated with the APOE4 genetic variant has achieved good interim results according to the company.

Research led by the University of Michigan shows that Black patients have significantly fewer medical tests in the emergency department than White

New York-based medtech startup Ataraxis AI has emerged from stealth mode, announcing $4 million in seed funding.

A test detecting the contents of extracellular vesicles in the plasma could help bring a blood test for early Parkinson's to the clinic.